Superinfections in patients treated with teicoplanin as anti SARSCoV2 AGENT

G Ceccarelli, F Alessandri, A Oliva… - European Journal of …, 2021 - iris.uniroma1.it
We read with interest the paper by Giacobbe et al. estimating a cumulative risk of developing
at least one bloodstream infection (BSI) episode (largely due to Gram-positive pathogens) of …

[HTML][HTML] Efficacy of teicoplanin in bloodstream infections caused by Enterococcus faecium: posthoc analysis of a nationwide surveillance

S Ha, K Huh, DR Chung, JH Ko, SY Cho… - International Journal of …, 2022 - Elsevier
Objectives Vancomycin and teicoplanin are glycopeptides with activity against Enterococcus
faecium. However, studies on the clinical efficacy of teicoplanin are limited. This study aimed …

Plasma trough concentration distribution and safety of high‐dose teicoplanin for patients with augmented renal clearance

S Hu, T Wang, H You, S Chen… - Journal of Clinical …, 2022 - Wiley Online Library
Abstract What Is Known and Objective There are few reports on the distribution of the
plasma trough concentration (C min) of teicoplanin in patients with augmented renal …

Are antibiotics appropriately dosed in critically ill patients with augmented renal clearance? A narrative review

M Sistanizad, R Hassanpour… - International Journal of …, 2022 - Wiley Online Library
Aims. Augmented renal clearance (ARC), which is commonly defined as increased renal
clearance above 130 ml/min/1.73 m2, is a common phenomenon among critically ill …

Therapeutics for vancomycin-resistant enterococcal bloodstream infections

KA Cairns, AA Udy, TN Peel, IJ Abbott… - Clinical Microbiology …, 2023 - Am Soc Microbiol
Vancomycin-resistant enterococci (VRE) are common causes of bloodstream infections
(BSIs) with high morbidity and mortality rates. They are pathogens of global concern with a …

Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant …

XS Zhang, YL Chen, YZ Wang, C Chen… - British Journal of …, 2024 - Wiley Online Library
Aims This study aims to establish a population pharmacokinetic (PK) model of teicoplanin in
Chinese adult patients to evaluate the dosing regimen in the label sheet and optimize it …

Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies

YW Wang, HA Hou, CC Lin, HY Lin, PZ Chen… - Advances in …, 2024 - Springer
Methods This single-center, prospective study enrolled patients with hematological
malignancies who were treated with teicoplanin either as an empirical antibiotic for FN or as …

Dose optimization of teicoplanin for critically ill patients with renal dysfunction and continuous renal replacement therapy: experience from a prospective interventional …

L Shi, Z Zhuang, L Duan, C Zhu, H Xue… - Frontiers in …, 2022 - frontiersin.org
Background: Due to the lack of updated information on teicoplanin (TEI) for continuous renal
replacement therapy (CRRT), no exact dosage regimen has been recommended. The aim of …

Therapeutic drug monitoring and nephrotoxicity of teicoplanin therapy in Chinese children: a retrospective study

D Sun, T Zhang, J Mi, Y Dong, Y Liu… - Infection and Drug …, 2020 - Taylor & Francis
Purpose This study aims to 1) describe the distribution characteristics of teicoplanin trough
concentration (C min) and explore the related influencing factors and 2) evaluate the …

Retrospective evaluation of an intervention bundle on OPAT implementation in a large non-university hospital

L Missiaen, D Vogelaers, PJ De Roo… - Acta Clinica …, 2024 - Taylor & Francis
Objectives Optimization of outpatient parenteral antimicrobial therapy (OPAT) requires
interdisciplinarity and an operational algorithm. This report retrospectively assesses the …